A Midazolam Drug Interaction Study With PF-04171327

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Healthy Volunteers

Interventions

DRUG

PF-04171327 25 mg

One 25 mg tablet administered once a day for 15 days

DRUG

Midazolam 2 mg

Midazolam oral syrup 2mg dose administered once on Day 1 and once on Day 15

Trial Locations (1)

Pfizer Investigational Site, New Haven